Skip to Content

Can a failed lung grow back?


A failed lung, also known as lung failure, refers to a condition where one or both lungs are unable to oxygenate the blood and remove carbon dioxide adequately. This can occur due to various lung diseases that damage the lungs, such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, cystic fibrosis, and acute respiratory distress syndrome (ARDS). When lung function drops below a certain threshold, it is considered lung failure. This is a serious and potentially life-threatening condition that requires prompt medical treatment. The main question many patients and researchers have is whether a failed lung can heal and regrow back to normal function.

What causes lung failure?

There are a few key causes of lung failure:

– Chronic obstructive pulmonary disease (COPD) – COPD is a progressive disease that makes it hard to breathe due to damaged airways and air sacs in the lungs. The main causes are smoking and long-term exposure to lung irritants.

– Pulmonary fibrosis – This condition causes scarring and thickening of the lung tissue, leading to stiff lungs that cannot expand and contract normally. It may be caused by infections, radiation therapy, air pollution, or medications.

– Cystic fibrosis – This is a genetic disorder that causes mucus to build up in the lungs and pancreas, leading to repeated infections and respiratory failure.

– Acute respiratory distress syndrome (ARDS) – ARDS is a rapid, serious lung condition caused by inflammation of the lungs. It can arise due to sepsis, trauma, inhaled toxins, or other critical illnesses.

– Other causes – Lung cancer, pneumonia, tuberculosis, emphysema, pulmonary embolism, and interstitial lung disease can also lead to lung failure if the damage is severe enough.

How do doctors assess lung failure?

Doctors use several tests to evaluate how well the lungs are working and determine if a patient has lung failure. These include:

– Spirometry – This breathing test measures how much air the lungs can hold and how fast air can move in and out. It assesses airflow obstruction that occurs in COPD and other lung diseases.

– Arterial blood gas – A blood sample is taken from an artery to measure oxygen and carbon dioxide levels. This helps assess how well the lungs are oxygenating blood.

– Imaging – Chest X-rays, CT scans, and MRIs provide images of the lungs to visualize damage, inflammation, and reduced air capacity.

– Lung function tests – These measure how well the lungs take in and circulate oxygen and remove carbon dioxide.

– Pulse oximetry – This noninvasive test uses a sensor on the finger to measure oxygen saturation in the blood. Low levels indicate respiratory failure.

What happens when lung function fails?

When the lungs can no longer provide enough oxygen to the body’s organs and tissues, it leads to serious complications:

– Hypoxemia – Low oxygen levels in the blood cause tissues and vital organs to suffer oxygen deprivation.

– Respiratory acidosis – Carbon dioxide builds up in the blood, causing the pH to drop and blood to become acidic.

– Pulmonary hypertension – Pressure increases in the pulmonary arteries as the heart struggles to pump against stiff, damaged lungs. This can lead to heart failure.

– Complications in other organs – Oxygen starvation affects vital organs like the brain, heart, liver, and kidneys. This can lead to organ dysfunction or failure.

– Death – Without treatment, respiratory failure can be fatal as the body’s systems shut down from lack of oxygen. Mechanical ventilation may be required to assist breathing.

Can the lungs heal and recover function?

The potential for lung recovery depends on the underlying cause and severity of the lung damage:

– Mild disease – For mild COPD or pulmonary fibrosis, quitting smoking and taking medications to dilate airways and reduce inflammation can help improve lung function slightly.

– Moderate disease – The lungs have limited ability to heal from substantial damage caused by diseases like moderate COPD or cystic fibrosis. However, with treatment, lung function may improve modestly or progress more slowly.

– End-stage disease – With severe, end-stage lung disease, significant recovery is unlikely. Treatments focus on supporting remaining lung function and managing symptoms. A lung transplant may be an option for some patients.

– ARDS – Many patients who survive ARDS recover most lung function, as the lungs can heal from severe inflammation if the inciting cause resolves. But recovery takes time.

So while mild recovery is possible in some cases, chronic, advanced lung diseases usually cause permanent scarring and reduced lung capacity.

Can new lungs regenerate and grow back?

Unfortunately, the lungs have very limited regenerative power to regrow or replace scarred and damaged lung tissue:

– Damaged alveoli – The tiny air sacs in the lungs (alveoli) that transfer oxygen to the blood do not regenerate well after injury.

– Loss of capillaries – The small blood vessels that surround the alveoli are also not replenished easily after being destroyed.

– Stem cell deficiency – Lungs have few resident stem cells compared to some other organs like the skin or intestines. Stem cells repair damage by dividing and maturing into specialized cells.

– Scar tissue – Fibrotic, stiff scar tissue that replaces elastic lung tissue in conditions like pulmonary fibrosis cannot be reversed or removed.

– Age-related cell loss – Lung capacity naturally declines with age as alveoli are lost and supporting elastic fibers degrade. This cannot be reversed.

– Genetic factors – In diseases like cystic fibrosis, the underlying genetic mutation continues to cause lung damage regardless of any localized lung tissue regeneration.

So while some natural lung cell turnover and renewal occurs, whole new lungs essentially cannot regrow or regenerate once seriously damaged. Research into stem cell and molecular therapies to induce lung regeneration is ongoing.

Can a lung transplant help restore lung function?

For patients with end-stage lung disease, a lung transplant may be an option to replace the damaged lungs and restore function. Key points about lung transplants include:

– Availability – There is a shortage of donor lungs available for transplantation. Patients may wait months or years for a suitable deceased donor.

– Risks – Transplants are high-risk surgeries. Complications like infections, rejection, and side effects of immunosuppressant medications can arise.

– Recovery – If successful, lung function can be restored to near normal levels with intensive rehabilitation. But lung capacity is lower than healthy people due to the smaller size of donor lungs.

– Long term outlook – For cystic fibrosis and pulmonary fibrosis patients, the 5-year survival rate after transplant is about 50%, while for COPD it is around 40%.

So while transplants can be life-saving for some patients with end-stage lung disease, they have limitations. Researchers hope bioengineered lungs may eventually provide an alternative solution.

Experimental approaches to lung regeneration

Because the lungs have little natural regenerative capacity, researchers are experimenting with novel ways to recreate lung tissue in the lab and trigger lung regeneration in the body:

– Stem cell research – Scientists are working to identify lung stem cells and develop methods to grow specialized lung cells from stem cells. These could be used to engineer new lung tissue patches.

– Biomaterials – Biocompatible scaffolds made from materials like collagen and hydrogels can allow lung cells to grow into 3D structures resembling alveoli.

– Bioreactors – Bioreactors mimick the mechanical stimulation of breathing to condition lab-grown lung cells and tissues. This improves their development and function.

– Molecular triggers – Growth factors, small molecules, and gene therapies are being tested to see if they can stimulate lung cell renewal, reduce scarring, and promote regeneration in damaged lungs.

– 3D printing – 3D printed scaffolds with lung cells are being developed that could eventually be implanted or used as extracellular matrix patches to help regenerate damaged lung regions.

While still highly experimental, these cutting-edge approaches offer hope for possibly stimulating true lung regeneration after injury in the future.

Conclusion

In summary, the adult lungs generally have a poor inherent ability to fully heal and regrow once they have suffered substantial damage from diseases like COPD, pulmonary fibrosis, or ARDS. While some recovery may occur with treatment in milder cases, end-stage disease usually causes permanent lung damage and reduced function. Lung transplants can restore function for some patients but have limitations. Therefore, researchers are pursuing experimental regenerative medicine approaches using stem cells, biomaterials, molecular signaling, and 3D printing to try to unlock the lungs’ latent regenerative potential and enable true lung regrowth. If these strategies succeed in the future, they could provide a revolutionary solution for restoring lung function in patients with respiratory failure. But for now, preventing lung damage through public health measures remains imperative, as damaged lungs cannot be readily fixed or regrown.